XML 104 R91.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidating Financial Information Statement of Cash Flows (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Dec. 31, 2017
Dec. 31, 2016
Condensed Cash Flow Statements, Captions [Line Items]            
Net cash (used in) provided by operating activities     $ 220,941 $ 122,697    
Capital expenditures $ (11,274) $ (13,465) (24,947) (28,099)    
Net proceeds from the sale of business     0 554,487    
Sale of partial interest of equity method investment     833 0    
Proceeds from sales of real estate and other assets     58 59,751    
Proceeds from the sale of investments     3,057 4,950    
Other, net     3,255 805    
Net cash (used in) provided by investing activities     (17,744) 591,894    
Long-term borrowings     0 202,694    
Repayments of long-term debt     0 (589,661)    
Long-term debt issuance costs     0 (1,689)    
Payments of dividends     (43,847) (542,665)    
Tax withholdings related to net share settlements of share-based awards     (5,723) (7,351)    
Proceeds from stock option exercises     581 10,013    
(Distributions to)/contributions from noncontrolling interests     (2) 1,003    
Change in intercompany receivables and payables and intercompany contributions (1)     0 0 [1]    
Net cash used in financing activities     (48,991) (927,656)    
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash     154,206 (213,065)    
Cash, cash equivalents and restricted cash, beginning of period (1)     691,251 611,198 [2] $ 611,198 [2]  
Cash, cash equivalents and restricted cash, end of period 845,457 398,133 845,457 398,133 691,251  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]            
Cash and cash equivalents 828,850 380,567 828,850 380,567 673,685  
Restricted cash and cash equivalents 16,607 17,566 16,607 17,566 17,566 $ 17,566
Cash, cash equivalents and restricted cash, end of period 845,457 398,133 845,457 398,133 691,251  
Non-cash settlement of intercompany balances       54,000    
Eliminations            
Condensed Cash Flow Statements, Captions [Line Items]            
Net cash (used in) provided by operating activities     0 0    
Capital expenditures     0 0    
Net proceeds from the sale of business       0    
Sale of partial interest of equity method investment     0      
Proceeds from sales of real estate and other assets     0 0    
Proceeds from the sale of investments     0 0    
Other, net     0 0    
Net cash (used in) provided by investing activities     0 0    
Long-term borrowings       0    
Repayments of long-term debt       0    
Long-term debt issuance costs       0    
Payments of dividends     0 0    
Tax withholdings related to net share settlements of share-based awards     0 0    
Proceeds from stock option exercises     0 0    
(Distributions to)/contributions from noncontrolling interests     0 0    
Change in intercompany receivables and payables and intercompany contributions (1)     0 0 [1]    
Net cash used in financing activities     0 0    
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash     0 0    
Cash, cash equivalents and restricted cash, beginning of period (1)     0 0 0  
Cash, cash equivalents and restricted cash, end of period 0 0 0 0 0  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]            
Cash and cash equivalents 0 0 0 0 0  
Restricted cash and cash equivalents 0 0 0 0 0  
Cash, cash equivalents and restricted cash, end of period 0 0 0 0 0  
Parent (Tribune Media Company) | Reportable Legal Entities            
Condensed Cash Flow Statements, Captions [Line Items]            
Net cash (used in) provided by operating activities     (83,042) (142,822)    
Capital expenditures     (6,087) (1,069)    
Net proceeds from the sale of business       574,817    
Sale of partial interest of equity method investment     0      
Proceeds from sales of real estate and other assets     0 0    
Proceeds from the sale of investments     0 4,950    
Other, net     0 0    
Net cash (used in) provided by investing activities     (6,087) 578,698    
Long-term borrowings       202,694    
Repayments of long-term debt       (587,636)    
Long-term debt issuance costs       (1,689)    
Payments of dividends     (43,847) (542,665)    
Tax withholdings related to net share settlements of share-based awards     (5,723) (7,351)    
Proceeds from stock option exercises     581 10,013    
(Distributions to)/contributions from noncontrolling interests     0 0    
Change in intercompany receivables and payables and intercompany contributions (1)     291,389 293,696 [1]    
Net cash used in financing activities     242,400 (632,938)    
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash     153,271 (197,062)    
Cash, cash equivalents and restricted cash, beginning of period (1)     687,868 592,204 592,204  
Cash, cash equivalents and restricted cash, end of period 841,139 395,142 841,139 395,142 687,868  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]            
Cash and cash equivalents 824,532 377,576 824,532 377,576 670,302  
Restricted cash and cash equivalents 16,607 17,566 16,607 17,566 17,566  
Cash, cash equivalents and restricted cash, end of period 841,139 395,142 841,139 395,142 687,868  
Guarantor Subsidiaries | Reportable Legal Entities            
Condensed Cash Flow Statements, Captions [Line Items]            
Net cash (used in) provided by operating activities     330,300 266,895    
Capital expenditures     (18,785) (24,841)    
Net proceeds from the sale of business       (8,168)    
Sale of partial interest of equity method investment     833      
Proceeds from sales of real estate and other assets     58 59,751    
Proceeds from the sale of investments     3,057 0    
Other, net     1,642 0    
Net cash (used in) provided by investing activities     (13,195) 26,742    
Long-term borrowings       0    
Repayments of long-term debt       0    
Long-term debt issuance costs       0    
Payments of dividends     0 0    
Tax withholdings related to net share settlements of share-based awards     0 0    
Proceeds from stock option exercises     0 0    
(Distributions to)/contributions from noncontrolling interests     0 0    
Change in intercompany receivables and payables and intercompany contributions (1)     (317,176) (300,109) [1]    
Net cash used in financing activities     (317,176) (300,109)    
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash     (71) (6,472)    
Cash, cash equivalents and restricted cash, beginning of period (1)     1,501 7,378 7,378  
Cash, cash equivalents and restricted cash, end of period 1,430 906 1,430 906 1,501  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]            
Cash and cash equivalents 1,430 906 1,430 906 1,501  
Restricted cash and cash equivalents 0 0 0 0 0  
Cash, cash equivalents and restricted cash, end of period 1,430 906 1,430 906 1,501  
Non-Guarantor Subsidiaries | Reportable Legal Entities            
Condensed Cash Flow Statements, Captions [Line Items]            
Net cash (used in) provided by operating activities     (26,317) (1,376)    
Capital expenditures     (75) (2,189)    
Net proceeds from the sale of business       (12,162)    
Sale of partial interest of equity method investment     0      
Proceeds from sales of real estate and other assets     0 0    
Proceeds from the sale of investments     0 0    
Other, net     1,613 805    
Net cash (used in) provided by investing activities     1,538 (13,546)    
Long-term borrowings       0    
Repayments of long-term debt       (2,025)    
Long-term debt issuance costs       0    
Payments of dividends     0 0    
Tax withholdings related to net share settlements of share-based awards     0 0    
Proceeds from stock option exercises     0 0    
(Distributions to)/contributions from noncontrolling interests     (2) 1,003    
Change in intercompany receivables and payables and intercompany contributions (1)     25,787 6,413 [1]    
Net cash used in financing activities     25,785 5,391    
Net Increase (Decrease) in Cash, Cash Equivalents and Restricted Cash     1,006 (9,531)    
Cash, cash equivalents and restricted cash, beginning of period (1)     1,882 11,616 11,616  
Cash, cash equivalents and restricted cash, end of period 2,888 2,085 2,888 2,085 1,882  
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations [Abstract]            
Cash and cash equivalents 2,888 2,085 2,888 2,085 1,882  
Restricted cash and cash equivalents 0 0 0 0 0  
Cash, cash equivalents and restricted cash, end of period $ 2,888 $ 2,085 $ 2,888 $ 2,085 $ 1,882  
[1] (1)Excludes the impact of a $54 million non-cash settlement of intercompany balances upon dissolution of certain Guarantor subsidiaries.
[2] (1)Cash, cash equivalents and restricted cash at the beginning of the six months ended June 30, 2017 of $611 million are comprised of $595 million of cash, cash equivalents and restricted cash from continuing operations as reflected in the Company’s unaudited Condensed Consolidated Balance Sheets and $16 million of cash, cash equivalents and restricted cash reflected in current assets of discontinued operations.